Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” ...

Large-language models are excellent for general-use AI systems, but they don’t understand pharmaceutical companies’ ...

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

DUBLIN--(BUSINESS WIRE)--The "Efficient Batch Record Design and Review" training has been added to ResearchAndMarkets.com's offering. This online training is designed for professionals in the ...

Linlin Sun and Xia Zheng of AFD China Intellectual Property Law Office cite two key Chinese Supreme People’s Court cases to clarify the conditions under which supplementary experimental data is ...

Despite the Supreme Court’s proposal to lower the bar for post-filing patent data, innovators are sceptical that the provisions will have real impact Multinational pharmaceutical companies in China ...